secwatch / observer
8-K filed May 1, 2023, 7:59 PM ET ticker BIO CIK 0000012208
other material confidence high sentiment neutral materiality 0.15

Bio-Rad annual meeting results: directors elected, say-on-pay approved, political disclosure rejected

BIO-RAD LABORATORIES, INC.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote on the frequency of future advisory votes to approve executive compensation at the 2023-04-25 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-04-25
Exact text from the filing
4 With respect to the non-binding advisory vote on the frequency of future advisory votes to approve executive compensation, Three Years received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Votes Broker 1 Year 2 Years 3 Years Abstaining Non-Votes 1,575,550 14,432 5,461,754 989 225,785
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-RAD LABORATORIES, INC. shareholders rejected Stockholder proposal regarding political disclosure at the 2023-04-25 meeting.

Outcome
failed
Meeting
2023-04-25
Exact text from the filing
5. The stockholder proposal regarding political disclosure was not approved since the proposal did not receive the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 1,100,154 5,935,081 17,489 225,785
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-RAD LABORATORIES, INC. shareholders approved Election of Directors at the 2023-04-25 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-04-25
Exact text from the filing
1. Each of the nominated directors was elected and received the affirmative vote of a majority of the votes cast in the respective class of Common Stock, as follows: Class of Common Stock Votes Votes Votes Broker to Elect For Against Abstaining Non-Votes Melinda Litherland Class A 14,950,990 5,818,104 4,785 1,695,304 Arnold A. Pinkston Class A 15,729,846 5,037,217 6,816 1,695,304 Jeffrey L. Edwards Class B 4,974,972 275 90 56,255 Gregory K. Hinckley Class B 4,974,972 275 90 56,255 Allison Schwartz Class B 4,972,669 2,578 90 56,255 Norman Schwartz Class B 4,972,669 2,578 90 56,255
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-RAD LABORATORIES, INC. shareholders approved Ratification of selection of KPMG LLP as independent auditors at the 2023-04-25 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-04-25
Exact text from the filing
2. The proposal to ratify the selection of KPMG LLP as the Company’s independent auditors for the fiscal year ending December 31, 2023 was ratified and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 7,258,298 19,666 547 -
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

BIO-RAD LABORATORIES, INC. shareholders approved Non-binding advisory vote to approve executive compensation at the 2023-04-25 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-04-25
Exact text from the filing
3. The non-binding advisory vote to approve executive compensation was approved and received the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock, as follows: Votes Votes Votes Broker For Against Abstaining Non-Votes 6,772,070 277,497 3,158 225,785
View on SEC.gov

147 shareholder votes filed in the last 30 days. Browse all shareholder votes →

BIO-RAD LABORATORIES, INC. filing history →

Source: SEC EDGAR
accession 0000012208-23-000041
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.